Today the Supreme Court agreed to review the Myriad gene patenting case, Association for Molecular Pathology v. Myriad Genetics. The case involved the patentability of genes directed to detection of breast cancer (BRCA genes) and methods for using them. The review is limited to question 1, which asks whether human genes are patentable. I previously wrote about the case here and here; SCOTUSblog's case page is here.
Friday, November 30, 2012
Sunday, November 25, 2012
Some of you might have dogs, some might have cats, some might have both. But here's a good reason to be glad none of your human friends act like dogs or cats. At least I hope none of them do.